Role of Bacteria in the Incidence of Common GIT Cancers: The Dialectical Role of Integrated Bacterial DNA in Human Carcinogenesis

References

• Gargano LM, Hughes JM. Microbial origins of chronic diseases. Annual Review of Public Health. 2014;35(1):65–82. doi:10.1146/annurev-publhealth-032013-182426
   Web of Science ®Google Scholar
• Van Elsland D, Neefjes J. Bacterial infections and cancer. EMBO Rep. 2018;19(11):e46632. doi:10.15252/embr.20184663230348892
   PubMed Web of Science ®Google Scholar
• Chang AH, Parsonnet J. Role of bacteria in oncogenesis. Clin Microbiol Rev. 2010;23(4):837–857.20930075
   PubMed Web of Science ®Google Scholar
• Berg RD. The indigenous gastrointestinal microflora. Tren Microbiol. 1996;4(11):430–435.
   PubMed Web of Science ®Google Scholar
• Muzaheed. Helicobacter pylori oncogenicity: mechanism, prevention, and Risk Factors. Sci World J. 2020;3018326.
   Google Scholar
• Haghi F, Goli E, Mirzaei B, Zeighami H. The association between fecal enterotoxigenic B. fragilis with colorectal cancer. BMC Cancer. 2019;19(1):1–4.30606139
   PubMed Web of Science ®Google Scholar
• Basset C, Holton J, Bazeos A, Vaira D, Bloom S. Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Digest Dis An–d Sci. 2004;49(9):1425–1432.
   PubMed Web of Science ®Google Scholar
• Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? lancet. 2001;357(9255):539–545.11229684
   PubMed Web of Science ®Google Scholar
• Cummins J, Tangney M. Bacteria and tumours: causative agents or opportunistic inhabitants? Infect Agents Cancer. 2013;8(1):1–8.
   Web of Science ®Google Scholar
• Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology. 2009;136(6):1863–1873. doi:10.1053/j.gastro.2009.01.07319457415
   PubMed Web of Science ®Google Scholar
• Polk DB, Peek RM. Helicobacter pylori: gastric cancer and beyond. Nature Reviews Cancer. 2010;10(6):403–414. doi:10.1038/nrc285720495574
   PubMed Web of Science ®Google Scholar
• Robinson KM, Sieber KB, Hotopp JCD. A review of bacteria-animal lateral gene transfer may inform our understanding of diseases like cancer. PLoS Genet. 2013;9(10):e1003877.24146634
   PubMed Web of Science ®Google Scholar
• Koshiol J, Wozniak A, Cook P, et al. Salmonella enterica serovar Typhi and gallbladder cancer: a case–control study and meta-analysis. Cancer Med. 2016;5(11):33103235.
   Web of Science ®Google Scholar
• Schöllkopf C, Melbye M, Munksgaard L, et al. Borrelia infection and risk of non-Hodgkin lymphoma. Blood. 2008;111(12):5524–5529.18424667
   PubMed Web of Science ®Google Scholar
• Eyvazi S, Vostakolaei MA, Dilmaghani A, et al. The oncogenic roles of bacterial infections in development of cancer. Microb Pathog. 2020;141:104019. doi:10.1016/j.micpath.2020.10401932006638
   PubMed Web of Science ®Google Scholar
• Luu TH, Michel C, Bard J-M, Dravet F, Nazih H, Bobin-Dubigeon C. Intestinal proportion of Blautia sp. is associated with clinical stage and histoprognostic grade in patients with early-stage breast cancer. Nutr Cancer. 2017;69(2):267–275.28094541
   PubMed Web of Science ®Google Scholar
• Tolg C, Sabha N, Cortese R, et al. Uropathogenic E. coli infection provokes epigenetic downregulation of CDKN2A (p16INK4A) in uroepithelial cells. Lab Invest. 2011;91(6):825–836.21242958
   PubMed Web of Science ®Google Scholar
• Zaidi AH, Kelly LA, Kreft RE, et al. Associations of microbiota and toll- like receptor signaling pathway in esophageal adenocarcinoma. BMC Cancer. 2016;16(1):52. doi:10.1186/s12885-016-2093-826841926
   PubMed Web of Science ®Google Scholar
• Nemunaitis JM, Brown-Glabeman U, Soares H, et al. Gallbladder cancer: review of a rare orphan gastrointestinal cancer with a focus on populations of New Mexico. BMC Cancer. 2018;18(1):1–14.29291726
   PubMed Web of Science ®Google Scholar
• Backert S, Tegtmeyer N, Selbach M. The versatility of Helicobacter pylori CagA effector protein functions: the master key hypothesis. Helicobacter. 2010;15(3):163–176.20557357
   PubMed Web of Science ®Google Scholar
• Higashi H, Tsutsumi R, Muto S, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science. 2002;295(5555):683–686.11743164
   PubMed Web of Science ®Google Scholar
• Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res. 1994;305(2):253–264.7510036
   PubMed Web of Science ®Google Scholar
• Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncol (Williston Park). 2002;16:217–226, 229; discussion 230–212.
   Google Scholar
• Schetter AJ, Heegaard NH, Harris CC. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis. 2010;31(1):37–49.19955394
   PubMed Web of Science ®Google Scholar
• Okada F. Inflammation-related carcinogenesis: current findings in epidemiological trends, causes and mechanisms. Yonago Acta Med. 2014;57(2):65–72.25324587
   PubMed Web of Science ®Google Scholar
• Fishbein A, Hammock BD, Serhan CN, Panigrahy D. Carcinogenesis: failure of resolution of inflammation? Pharmacol Ther. 2020;107670. doi:10.1016/j.pharmthera.2020.10767032891711
   PubMed Web of Science ®Google Scholar
• Agassandian M, Shurin GV. Bacterial Infections and Cancer Development. Infect Cancer. 2015;49–74.
   Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–867.12490959
   PubMed Web of Science ®Google Scholar
• Pollard J. Bacteria, inflammation and cancer. Nat Rev Immunol. 2015;15(9):528.
   PubMed Web of Science ®Google Scholar
• Wu S, Rhee K-J, Albesiano E, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med. 2009;15(9):1016–1022.19701202
   PubMed Web of Science ®Google Scholar
• Gold JS, Bayar S, Salem RR. Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch Surg. 2004;139(7):760–765.15249410
   PubMedGoogle Scholar
• Biarc J, Nguyen IS, Pini A, et al. Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S. bovis). Carcinogenesis. 2004;25(8):1477–1484.14742316
   PubMed Web of Science ®Google Scholar
• Scanu T, Spaapen RM, Bakker JM, et al. Salmonella manipulation of host signaling pathways provokes cellular transformation associated with gallbladder carcinoma. Cell Host Microbe. 2015;17(6):763–774.26028364
   PubMed Web of Science ®Google Scholar
• Shukla VK, Singh H, Pandey M, Upadhyay S, Nath G. Carcinoma of the gallbladder—is it a sequel of typhoid? Dig Dis Sci. 2000;45(5):900–903.10795752
   PubMed Web of Science ®Google Scholar
• Goetze TO. Gallbladder carcinoma: prognostic factors and therapeutic options. World J Gastroenterol. 2015;21(43):12211–12217.26604631
   PubMed Web of Science ®Google Scholar
• Di Domenico EG, Cavallo I, Pontone M, Toma L, Ensoli F. Biofilm producing Salmonella typhi: chronic colonization and development of gallbladder cancer. Int J Mol Sci. 2017;18(9)).
   Web of Science ®Google Scholar
• Espinoza JA, Bizama C, García P, et al. The inflammatory inception of gallbladder cancer. BBA Rev Cancer. 2016;1865(2):245–254.
   Web of Science ®Google Scholar
• Cheng WT, Kantilal HK, Davamani F. The Mechanism of Bacteroides fragilis Toxin Contributes to Colon Cancer Formation. Malays J Med Sci. 2020;27(4):9.21.
   Web of Science ®Google Scholar
• Snezhkina AV, Krasnov GS, Lipatova AV, et al. The dysregulation of polyamine metabolism in colorectal cancer is associated with overexpression of c-Myc and C/EBPβ rather than enterotoxigenic Bacteroides fragilis infection. Oxid Med Cell Longev. 2016;2016:2353560. doi:10.1155/2016/235356027433286
   PubMed Web of Science ®Google Scholar
• Boleij A, Hechenbleikner EM, Goodwin AC, et al. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin Infect Dis. 2015;60(2):208–215.25305284
   PubMed Web of Science ®Google Scholar
• Sears CL, Geis AL, Housseau F. Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis. J Clin Invest. 2014;124(10):4166–4172.25105360
   PubMed Web of Science ®Google Scholar
• Wu S, Morin PJ, Maouyo D, Sears CL. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology. 2003;124(2):392–400.12557145
   PubMed Web of Science ®Google Scholar
• Yekani M, Baghi HB, Naghili B, Vahed SZ, Sóki J, Memar MY. To resist and persist: important factors in the pathogenesis of Bacteroides fragilis. Microb Pathog. 2020;149. doi:10.1016/j.micpath.2020.104506
   Web of Science ®Google Scholar
• Chung L, Orberg ET, Geis AL, et al. Bacteroides fragilis toxin coordinates a pro-carcinogenic inflammatory cascade via targeting of colonic epithelial cells. Cell Host Microbe. 2018;23(2):203–214.29398651
   PubMed Web of Science ®Google Scholar
• Hwang S, Gwon S-Y, Kim MS, Lee S, Rhee K-J. Bacteroides fragilis toxin induces IL-8 secretion in HT29/C1 cells through disruption of E-cadherin junctions. Immu Netw. 2013;13(5):213–217.
   Google Scholar
• Cancer IAfRo. Agents classified by the IARC Monographs, volumes 1-106. http://monographs.. iarc. fr/ENG/Classification/index. php. 2012.
   Google Scholar
• Group I. Helicobacter pylori eradication as a strategy for preventing gastric cancer. IARC Working Group Reports. 2014.
   Google Scholar
• Yong X, Tang B, Li B-S, et al. Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways. Cell Commun Sign. 2015;13(1):1–13.
   PubMed Web of Science ®Google Scholar
• Servetas SL, Bridge DR, Merrell DS. Molecular mechanisms of gastric cancer initiation and progression by. Helicobacter Pylori. Curr Opin Infect Dis. 2016;29(3):304–310.26779778
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.21376230
   PubMed Web of Science ®Google Scholar
• Hartung ML, Gruber DC, Koch KN, et al. H. pylori-induced DNA strand breaks are introduced by nucleotide excision repair endonucleases and promote NF-κB target gene expression. Cell Rep. 2015;13(1):70–79.26411687
   PubMed Web of Science ®Google Scholar
• Maekita T, Nakazawa K, Mihara M, et al. High levels of aberrant DNA methylation in Helicobacter pylori–infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res. 2006;12(3):989–995.16467114
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Marusawa H, Kinoshita K, et al. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med. 2007;13(4):470–476.17401375
   PubMed Web of Science ®Google Scholar
• Koeppel M, Garcia-Alcalde F, Glowinski F, Schlaermann P, Meyer TF. Helicobacter pylori infection causes characteristic DNA damage patterns in human cells. Cell Rep. 2015;11(11):1703–1713.26074077
   PubMed Web of Science ®Google Scholar
• Ansari S, Yamaoka Y. Helicobacter pylori virulence factor cytotoxin- associated Gene A (CagA)-mediated gastric pathogenicity. Int J Mol Sci. 2020;21(19):7430. doi:10.3390/ijms21197430
   Web of Science ®Google Scholar
• Ansari S, Yamaoka Y. Role of vacuolating cytotoxin A in Helicobacter pylori infection and its impact on gastric pathogenesis. Expert Rev Anti Infect Ther. 2020;18(10):987–996.32536287
   PubMed Web of Science ®Google Scholar
• Zhao Q, Yin W, Zhao R, et al. Outer inflammatory protein of Helicobacter pylori impacts IL-8 expression, adherence, cell apoptosis and cell cycle of gastric cells independent of its copy number. Med Microbiol Immunol. 2020;209(5):621–630.32607764
   PubMed Web of Science ®Google Scholar
• Hayashi T, Senda M, Morohashi H, et al. Tertiary structure-function analysis reveals the pathogenic signaling potentiation mechanism of Helicobacter pylori oncogenic effector CagA. Cell Host Microbe. 2012;12(1):20–33.22817985
   PubMed Web of Science ®Google Scholar
• Ohnishi N, Yuasa H, Tanaka S, et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci. 2008;105(3):1003–1008.18192401
   PubMed Web of Science ®Google Scholar
• Stein M, Rappuoli R, Covacci A. The cag pathogenicity island. Helicobacter Pylori: Physiol Gen. 2001;345–353.
   Google Scholar
• Selbach M, Paul FE, Brandt S, et al. Host cell interactome of tyrosine- phosphorylated bacterial proteins. Cell Host Microbe. 2009;5(4):397–403.19380118
   PubMed Web of Science ®Google Scholar
• Zeaiter Z, Cohen D, Müsch A, Bagnoli F, Covacci A, Stein M. Analysis of detergent-resistant membranes of Helicobacter pylori infected gastric adenocarcinoma cells reveals a role for MARK2/Par1b in CagA-mediated disruption of cellular polarity. Cell Microbiol. 2008;10(3):781–794.18005242
   PubMed Web of Science ®Google Scholar
• Yamahashi Y, Hatakeyama M. PAR1b takes the stage in the morphogenetic and motogenetic activity of Helicobacter pylori CagA oncoprotein. Cell Adh Migr. 2013;7(1):11–17.23076215
   PubMed Web of Science ®Google Scholar
• Murata-Kamiya N, Kurashima Y, Teishikata Y, et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the β-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene. 2007;26(32):4617–4626.17237808
   PubMed Web of Science ®Google Scholar
• Suzuki M, Mimuro H, Kiga K, et al. Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe. 2009;5(1):23–34.19154985
   PubMed Web of Science ®Google Scholar
• Lei H, Tao K. Somatic mutations in colorectal cancer are associated with the epigenetic modifications. J Cell Mol Med. 2020;24(20):11828–11836.32865336
   PubMed Web of Science ®Google Scholar
• Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. The Lancet. 2007;370(9590):890–907.
   PubMed Web of Science ®Google Scholar
• Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature. 2011;473(7346):174–180.21508958
   PubMed Web of Science ®Google Scholar
• Sieber KB Identification of bacterial DNA integration into the human cancer genome; 2016. https://archive.hshsl.umaryland.edu/handle/.
   Google Scholar
• Riley DR, Sieber KB, Robinson KM, et al. Bacteria-human somatic cell lateral gene transfer is enriched in cancer samples. PLoS Comput Biol. 2013;9(6):e1003107. doi:10.1371/journal.pcbi.100310723840181
   PubMed Web of Science ®Google Scholar
• Häcker G, Redecke V, Häcker H. Activation of the immune system by bacterial CpG‐DNA. Immunology. 2002;105(3):245–251.11918685
   PubMed Web of Science ®Google Scholar
• Sander LE, Davis MJ, Boekschoten MV, et al. Detection of prokaryotic mRNA signifies microbial viability and promotes immunity. Nature. 2011;474(7351):385–389.21602824
   PubMed Web of Science ®Google Scholar
• Wodarz D, Newell AC, Komarova NL. Passenger mutations can accelerate tumour suppressor gene inactivation in cancer evolution. J R Soc Interface. 2018;15(143):20170967. doi:10.1098/rsif.2017.096729875280
   PubMed Web of Science ®Google Scholar